PABLO VELASCO

Department Associate Professor

University of Barcelona

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pablo Velasco is an Associate Professor in the Department at Universitat Autònoma de Barcelona, Spain. His research areas include hematology, particularly the epidemiology and clinical management of blood disorders such as sickle cell disease and acute lymphoblastic leukemia. He has contributed to key studies on the impact of COVID-19 in patients with red blood cell disorders and the demographics and management of hemoglobinopathies in Spain.

Articles (22)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (9)

Jesús María Hernández-Rivas

Universidad de Salamanca

SPAIN

View details

Gabriel Fernández Calvo

Full Professor

University of Castilla-La Mancha

SPAIN

View details

Noel Peter

University of Oxford

UNITED KINGDOM

View details

Oscar Molina

SPAIN

View details

María del Mar Mañú Pereira

Head of the rare anemia disorders research lab

Vall d'Hebron Institut de Recerca

SPAIN

View details

Roger Colobran

Head of Translational Immunology Research Group

Vall d'Hebron Institut de Recerca

SPAIN

View details

Joan Montero

Associate Professor

University of Barcelona

SPAIN

View details

Lorraine Ochieng

De Montfort University

UNITED KINGDOM

View details

Michael Sullivan

Honorary Professor of Paediatrics

University of Otago Christchurch

NEW ZEALAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

PABLO VELASCO

Research Interests

Explore related searches

Contact this professor

About

Articles (22)

COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet

Daratumumab in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma: DELPHINUS Study

Cancer is not a risk factor for severe COVID‐19 in children, except in patients with recent allogeneic hematopoietic stem cell transplantation or comorbidities

Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia

Newborn Screening for Sickle Cell Disease in Catalonia between 2015 and 2022—Epidemiology and Impact on Clinical Events

Chromosomal instability in aneuploid acute lymphoblastic leukemia associates with disease progression

Inherited Thrombocytopenias Predisposing to Hematologic Neoplasms. Experience of the Spanish Group for Inherited Platelet Disorders (GEAPC)

Invasive Bacterial Infections in Children With Sickle Cell Disease: 2014–2019

The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)

The relapsed acute lymphoblastic leukemia network (ReALLNet): a multidisciplinary project from the spanish society of pediatric hematology and oncology (SEHOP)

PB1725: INTERNATIONAL LEUKEMIA TARGET BOARD - A PLATFORM TO DISCUSS AND PRIORITIZE TARGETED TREATMENT OPTIONS FOR PATIENTS WITH RELAPSED/REFRACTORY PEDIATRIC HEMATOLOGICAL MALIGNANCIES (ILTB) – ITCC 107

Communication transforms the impact of the <scp>COVID</scp>‐19 pandemic on children with cancer and their families

Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic.

Detection and evolutionary dynamics of somatic FAS variants in autoimmune lymphoproliferative syndrome: Diagnostic implications.

Clonal heterogeneity and rates of specific chromosome gains are risk predictors in childhood high-hyperdiploid B-cell acute lymphoblastic leukemia.

Utilizing Multilingual Methods and Rapid Analysis for Global Qualitative Research During a Pandemic.

Impact of the COVID-19 pandemic on paediatric patients with cancer in low-income, middle-income and high-income countries: protocol for a multicentre, international, observational cohort study.

Near-Haploidy and Low-Hypodiploidy in B-Cell Acute Lymphoblastic Leukemia: When Less Is Too Much

Resilient health care in global pediatric oncology during the COVID-19 pandemic.

ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19

Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study.

Is acute lymphoblastic leukemia with mature B-cell phenotype and <i>KMT2A</i> rearrangements a new entity? A systematic review and meta-analysis.

Collaborators (9)

Jesús María Hernández-Rivas

Gabriel Fernández Calvo

Noel Peter

Oscar Molina

María del Mar Mañú Pereira

Roger Colobran

Joan Montero

Lorraine Ochieng

Michael Sullivan

Make your next move.